Example collocations logo

Patent in sentence

392 examples of Patent in a sentence

NEF’s current cohort includes Somalia’s Abdigani Diriye, who created a blockchain-enabled lending platform in Kenya and was recently named one of Africa’s top 30 innovators;Nigeria’s Peter Ngene, whose work on nanotechnologies is being used to improve renewable energy and who also recently created a hydrogen-based eye sensor that detects lactose intolerance; and Vinet Coetzee of South Africa, whose research in non-invasive measures of health has led to a patent application for a device that could detect malaria.
Recent data for the U.S. Patent and Trademark Office tells an amazing story.
The tragedy of millions of impoverished people dying of AIDS even when drugs exist to treat them raises deep questions about global intellectual property rights, because patent protection is creating a barrier to essential medicines reaching the world's poor.
But how can the benefits of a global patent system that provides incentives for innovation and new discoveries be combined with an assurance that poor people gain access to the medical care that they desperately need?
In rich countries, patent protection should continue so that the pharmaceutical industry keeps innovating.
Any viable solution requires that the following conditions be satisfied:- drug companies – whether patent holders or generic drug producers – must provide drugs to poor countries at prices near to production costs;- drug prices in rich countries must remain higher through patent protection to preserve incentives for innovation;- rich and poor markets must be separated, so that cheap drugs from poor countries are not smuggled into rich countries (or are not allowed in legally through parallel-market imports);- governments in rich countries must provide substantial assistance to poor countries, so that the poor – who are too poor to afford these drugs even at reduced prices – can make use of them.
If politicians cave in here – say, by eliminating patent protection, imposing price controls, or allowing re-import of drugs from poor countries – innovation for new drugs will stall.
So, reform the international patent system to guarantee the poor access to essential medicines, but don’t kill the goose that lays the golden egg by undermining the patent system.
Last fall, during his visit to the US, Indian Prime Minister Narendra Modi agreed to establish a working group to reevaluate the country’s patent policy.
How might India tighten its patent system?
India could also stop issuing compulsory licenses to allow other companies to produce a patent holder’s drug, in exchange for a fee – an arrangement permitted under TRIPS, but anathema to the drug industry.
India’s current policies allow drugs to be sold at a small fraction of the monopoly prices commanded by patent holders.
If the US compels India to tighten its patent rules substantially, so that they resemble US rules more closely, this outcome could be jeopardized.
Of course, if America’s strong patent regime were, as its proponents claim, the best way to foster innovation in the pharmaceutical industry, the Obama administration’s policy toward India could perhaps be justified.
A patent that raises the price of a drug a hundred-fold has the same effect on the market as a 10,000% tariff.
If the Obama administration succeeds in forcing India to strengthen its patent laws, the change would harm not only India and other developing countries; it would also enshrine a grossly corrupt and inefficient patent system in the US, in which companies increase their profits by driving out the competition – both at home and abroad.
After all, generic drugs from India often provide the lowest-cost option in the US market once patent terms have expired.
In 2009, about 280,000 domestic patent applications were filed in China, placing it third globally, behind Japan and the United States.
China is fourth and rising in terms of international patent applications.
The US did have patent laws, but they protected only US citizens.
Even as it champions multilateral cooperation to ensure that MNCs pay their “fair” share, the British government has slashed its corporate rate, exempted the active foreign income of British MNCs from the national corporate tax, and enacted a “patent box” that stipulates a 10% tax rate on qualified patent income.
When Moore discovered in 1984 that he had become patent number 4,438,032, he sued for malpractice and property theft.
After the pioneering work of the Wright brothers and the Curtis brothers, overlapping patent claims thwarted the development of the airplane, until the United States government finally forced a patent pool as World War I loomed.
Today, many in the computer industry worry that such a patent thicket may impede software development.
Pharmaceutical companies argue that they should be entitled to a full patent, paying nothing to the developing country from which the traditional knowledge was taken, even though the country preserves the biodiversity without which the drug would never have come to market.
The TPP’s critics often neglected to acknowledge that international dispute-settlement mechanisms could ever serve a valid purpose, or that some degree of patent protection is needed if pharmaceutical companies are to have sufficient incentive to invest in research and development.
They recognized that patent rights, if exercised to excess, would be a death warrant for millions of poor people.
The two types of "post-academic" university that they represent--the one a diploma mill, the other a patent factory--share an overriding interest in benefiting those who can pay at the point of delivery.
EU leaders made some progress on creating a single financial market throughout the Union, and on establishing a standard European patent.
That is because we have created a patent system that gives innovators a temporary monopoly over what they create, which encourages them to hoard their knowledge, lest they help a competitor.
BackNext